Gamma-hydroxybutyrate Formulations with Improved Pharmacokinetics
Summary
The USPTO has published a new patent application, US20260083696A1, detailing modified release formulations of gamma-hydroxybutyrate with improved dissolution and pharmacokinetic properties. The application was filed on October 1, 2025, by inventors Jordan Dubow, Claire Megret, Hervé Guillard, and Jean-François Dubuisson.
What changed
The United States Patent and Trademark Office (USPTO) has published patent application US20260083696A1, titled 'Gamma-hydroxybutyrate formulations with improved pharmacokinetics.' This application, filed on October 1, 2025, by inventors Jordan Dubow, Claire Megret, Hervé Guillard, and Jean-François Dubuisson, describes novel modified release formulations of gamma-hydroxybutyrate designed to enhance dissolution and pharmacokinetic properties.
This publication represents a new patent filing and does not impose immediate compliance obligations. However, it is relevant for pharmaceutical companies and drug manufacturers involved in the development or research of gamma-hydroxybutyrate or similar formulations. Compliance officers should note this filing as it pertains to intellectual property within the pharmaceutical sector, potentially impacting future product development and market exclusivity.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
Application US20260083696A1 Kind: A1 Mar 26, 2026
Inventors
Jordan Dubow, Claire Megret, Hervé Guillard, Jean-François Dubuisson
Abstract
Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
CPC Classifications
A61K 31/22 A61K 9/14 A61K 9/1676 A61K 9/5015 A61K 9/5026 A61K 9/5042 A61K 9/5078 A61K 9/5084 A61K 31/19
Filing Date
2025-10-01
Application No.
19347400
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.